Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
87698393 |
LAW OFFICE ASSIGNED |
LAW OFFICE 108 |
MARK SECTION |
MARK |
TIMLOZE |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
TIMLOZE |
OWNER SECTION |
NAME |
Radius Health, Inc. |
STREET |
950 Winter Street |
CITY |
Waltham |
STATE |
Massachusetts |
ZIP/POSTAL CODE |
02451 |
COUNTRY |
United States |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Pharmaceutical preparations for use in the treatment of bone diseases, connective tissue diseases, inflammatory diseases, blood diseases and
hormonal disorders; Pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; Pharmaceutical preparations for use in
hormone therapy; Pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, cancer, gynecological diseases, rheumatic diseases,
urological diseases, gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases,
internal medicine diseases; Pharmaceutical preparations for use in the treatment of alopecia; Pharmaceutical preparations for use in the treatment of cognitive disorders and mood disorders;
Pharmaceutical preparations for use in the treatment of diabetes and insulin-related disorders and conditions; Pharmaceutical preparations to treat wounds and trauma |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
2 |
ONGOING EFFORT |
product or service research or development |
ALLOWANCE MAIL DATE |
06/12/2018 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
125 |
TOTAL AMOUNT |
125 |
SIGNATURE SECTION |
SIGNATURE |
/sarahannekeefe/ |
SIGNATORY'S NAME |
Sarah Anne Keefe |
SIGNATORY'S POSITION |
Attorney of record, Massachusetts Bar Member |
DATE SIGNED |
06/06/2019 |
SIGNATORY'S PHONE NUMBER |
857-287-3150 |
FILING INFORMATION |
SUBMIT DATE |
Thu Jun 06 14:34:51 EDT 2019 |
TEAS STAMP |
USPTO/ESU-XX.XX.X.XX-2019
0606143451923218-87698393
-620f7f199a9a98de7d636cca
11953232e7bbe89512f2e4da3
5c91817861a2446-DA-886-20
190606120745522555 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: TIMLOZE
SERIAL NUMBER: 87698393
The applicant, Radius Health, Inc., having an address of
950 Winter Street
Waltham, Massachusetts 02451
United States
requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 06/12/2018.
For International Class 005:
Current identification: Pharmaceutical preparations for use in the treatment of bone diseases, connective tissue diseases, inflammatory diseases, blood diseases and hormonal disorders; Pharmaceutical
preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; Pharmaceutical preparations for use in hormone therapy; Pharmaceutical
preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, cancer, gynecological diseases, rheumatic diseases, urological diseases,
gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases;
Pharmaceutical preparations for use in the treatment of alopecia; Pharmaceutical preparations for use in the treatment of cognitive disorders and mood disorders; Pharmaceutical preparations for use
in the treatment of diabetes and insulin-related disorders and conditions; Pharmaceutical preparations to treat wounds and trauma
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension
request: product or service research or development
A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /sarahannekeefe/ Date Signed: 06/06/2019
Signatory's Name: Sarah Anne Keefe
Signatory's Position: Attorney of record, Massachusetts Bar Member
Signatory's Phone: 857-287-3150
RAM Sale Number: 87698393
RAM Accounting Date: 06/07/2019
Serial Number: 87698393
Internet Transmission Date: Thu Jun 06 14:34:51 EDT 2019
TEAS Stamp: USPTO/ESU-XX.XX.X.XX-2019060614345192321
8-87698393-620f7f199a9a98de7d636cca11953
232e7bbe89512f2e4da35c91817861a2446-DA-8
86-20190606120745522555